title: Re: Prevalence and management of lower urinary tract symptoms in methamphetamine abusers: an under-recognized clinical identity: K. C. Koo, D. H. Lee, J. H. Kim, K. H. Rha, B. H. Chung, S. J. Hong and S. Y. Mah. J Urol 2014; 191: 722-726.
authors.affiliation: Department of Urology, Sakarya University School of Medicine, Sakarya, Turkey. Electronic address: aagokce@yahoo.com.
authors.forename: Ahmet
authors.initials: A
authors.lastname: Gokce
authors.affiliation: Department of Urology, Sakarya University School of Medicine, Sakarya, Turkey.
authors.forename: Sukru
authors.initials: S
authors.lastname: Kumsar
authors.affiliation: Department of Urology, Sakarya University School of Medicine, Sakarya, Turkey.
authors.forename: Fikret
authors.initials: F
authors.lastname: Halis
mesh_terms: D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use*; D018680:Cholinergic Antagonists / Q000627:therapeutic use*; D006801:Humans; D059411:Lower Urinary Tract Symptoms / Q000139:chemically induced* / Q000188:drug therapy*; D008297:Male; D008694:Methamphetamine / Q000633:toxicity*; D019966:Substance-Related Disorders / Q000150:complications*
chemical_list: D000317:Adrenergic alpha-Antagonists; D018680:Cholinergic Antagonists; D008694:Methamphetamine